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skin deep
Exploring the
Hidden World of
Dogs (and Humans)
BY MANASEE WAGH

Above: Penn Vet dermatologists use an instrument to measure pH
levels on the pinna of a dog’s ear.
Below: A device quantitates the sebum on the skin.

B

y current estimates, the human body contains
10 times more microbial cells than human cells.
Acting in ways both beneficial and harmful, the
microorganisms living on the surface of the skin,
as well as in the gut and other organs, constitute a complex
ecosystem known to influence digestion, allergies, and a
variety of diseases.
Scientists are more interested in the microbiome than
ever. At Penn Vet, researchers are crossing disciplines to
seek greater understanding of how these diverse populations
of “friendly” bacteria inhabit and interact with their host.
Penn Vet’s new Center for Research on Microbes in Health
and Disease is currently funding pilot projects that explore
the microbiomes of both human beings and animals.
“There’s increasing evidence that the microbiome
is important in regulating many diseases, and it may be
something we can control or manipulate, either through
dietary intervention, such as prebiotics or probiotics, or by
medical means,” said Dr. Dan Beiting, Research Assistant
Professor in Penn Vet’s Department of Pathobiology.
One of the collaborative studies the Center is funding
is a one-year, $50,000 project bringing together scientists
from Penn Vet and the Perelman School of Medicine.
Researchers will peer into the microbial world of dogs that
have atopic dermatitis, a common allergic skin condition.
Precipitated by allergens such as pollen, dust, and
molds, the disease is similar to human atopic dermatitis and
commonly occurs spontaneously in about 10 percent of
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“There’s increasing evidence that
the microbiome is important in
regulating many diseases, and it may
be something we can control or
manipulate, either through dietary
intervention, such as prebiotics or
probiotics, or by medical means.”
Penn Vet dermatologists measure transepidermal water loss on
the inside of a dog’s leg.

dogs. In both humans and dogs, atopic dermatitis is treated
with a wide array of interventions, some of which may
include antibiotics and corticosteroids. Veterinarians at Penn
Vet’s Ryan Hospital treat dogs that present with typical
symptoms such as itching and then progress to scabs, hair
loss, and secondary bacterial infections that can often be
resistant to antibiotic treatments.
Veterinary researchers will examine the bacterial
population on the dogs’ skin and follow changes in the
microbiome of each dog during treatment. The goal is to
understand the role of resistant microbial organisms in the
innate resistance to infection, the onset of infection, and the
development of antimicrobial resistance once infection does
occur.
“The skin is a wall between the body and the world.
We’re looking at the relationship between the bacteria and
the skin, and the different components of the dog’s skin
that affect its barrier function,” said Dr. Charles Bradley, a
Pathobiology Lecturer at Penn Vet. Dr. Bradley is part of
the research team, which brings together the knowledge
of people that specialize in human medicine and veterinary
dermatology, pathology, and microbiology.
Globally, researchers study the microbiome primarily
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—Dr. Dan Beiting, Research Assistant Professor in Penn
Vet’s Department of Pathobiology

in humans and in mouse models of disease, but very little
is known about the dog microbiome. Since dogs develop
spontaneous and complex diseases, much like humans, they
serve as ideal models for understanding how both animals
and humans can go from being healthy one day to dealing
with a chronic or recurring disease the next day.
Because culturing bacteria and other microbes in a
lab can be time consuming, and may be biased and error
prone, today’s researchers prefer genomic approaches such
as directly sequencing bacterial DNA from skin swabs to
identify the microbes that are present.
Dr. Elizabeth Grice, Assistant Professor of Dermatology at
Penn’s Perelman School of Medicine, is devoted to studying
the skin microbiome of humans. Instead of growing bacteria
in cultures, her approach to identifying bacteria starts
with observing them directly from a skin sample. She has
teamed up with Penn Vet researchers who will use her lab’s
methods to investigate atopic dermatitis.
“We’d normally use bacterial cultures, but those don’t
capture the full diversity of bacteria present on the skin.
Now we can target bacterial genes and identify the types
of bacteria present with greater precision than before,” Dr.
Grice said.

New diagnostic
equipment and
software allow Penn
Vet researchers to
measure the efficacy
of the skin barrier
directly on the skin.

This is a less biased method than growing bacteria by
microbiologic culture, because cultures are highly selective
for particular environments, nutrient sources, temperature,
and other growth conditions that may favor some types of
bacteria over others. By using genomic, culture-independent
approaches, researchers see a more precise picture of the
microbes.
“A whole-community analysis allows you to see that
many different organisms are present at time zero, and after
antimicrobial therapy, the population may have shifted to
two or five or 10 organisms that dominate the skin. We’d
recognize those as causing the infection, because those are
the ones that have overgrown,” said Dr. Shelley Rankin,
Associate Professor of Microbiology at Penn Vet and a
member of the project team.
In addition to assessing the dog microbiome, the
veterinary group will also be measuring the integrity of the
skin barrier, which is provided by the stratum corneum –
the topmost, non-porous layer that is the body’s first line of
defense against the environment.
“In humans with atopic skin disease, that skin barrier is
defective and allows allergens to penetrate the skin and cause
allergic reaction,” said Dr. Elizabeth Mauldin, Associate
Professor of Pathology and Dermatology at Penn Vet and
another researcher involved in this interdisciplinary study.
“We want to know what role the barrier plays in dogs
with allergic skin disease. Are they losing too much water
through their skin? What’s the pH, and is it different from
normal? In people, these characteristics could have a genetic
basis. We don’t really know that much about dogs yet."
A major complication following the treatment of atopic
dermatitis and similar skin infections that compromise the
natural defense mechanisms of the skin is that antibiotic
therapy can lead to the development of antibiotic-resistant

bacteria. Dogs that start with a mild case of itching may
progress to a drug-resistant staph infection.
Is the skin’s resident population of Staphylococcus
becoming resistant to antibiotics during antibiotic therapy?
According to Dr. Rankin, it may be that there are small
numbers of drug-resistant staphylococci already present
on the skin, and because antibiotics kill the susceptible
bacteria, those antibiotic-resistant bacteria get the chance to
propagate – unhindered.
“One of the goals of the study is to determine the
character of the skin’s microbiome during the development
of these complications,” said Dr. Dan Morris, a member of
the research team and Chief of the Section of Dermatology
and Allergy at Penn Vet.
The researchers will selectively look for genes associated
with drug-resistant strains of bacteria such as methicillinresistant Staphylococcus, before and after therapy.
“We see a shift toward resistant populations during
antimicrobial therapy, but we don’t have a good grasp right
now of how that occurs. Are we amplifying an existing
population? We’re spending a lot of time considering this
question,” Dr. Rankin added.
Scientists believe that the answers they find in the canine
microbiome will provide a better understanding of human
medical dilemmas such as drug-resistant bacterial infections
and the role of microorganisms in normal skin functioning.
Encouraged by the Center for Research on Microbes in
Health and Disease, this unique collaboration will bring
researchers closer to finding answers to these important
questions.
“Hopefully, what we discover will be used by
dermatologists in the human medical field, and lead to
prevention and treatment for people as well as for our
canine patients,” Dr. Rankin concluded.
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